<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-06-01</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgXlyjh3z">今天Lancet HIV发表了一项十分重要的HIV治愈前瞻性临床试验。这项研究非常重要，它报道了通过造血干细胞移植（HSCT）治愈HIV临床队列IciStem中患者病毒学标记物...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogxlyjh3z/">
    
    
    
    
    
      
    
    今天Lancet HIV发表了一项十分重要的HIV治愈前瞻性临床试验。这项研究非常重要，它报道了通过造血干细胞移植（HSCT）治愈HIV临床队列IciStem中患者病毒学标记物（biomarker）变化。目前5例HIV治愈病例全部是通过HSCT实现的（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->），而HSCT治愈HIV有4个机制，这也是我反复强调的：1.  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OgWL3b8wh">[憧憬][憧憬][憧憬] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ogwl3b8wh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OgXPkiVSZ">就很喜欢这些奇奇怪怪大儿童，以及女娲都补不了的大脑洞[笑cry] - 转发 @张怡微:&amp;ensp;🪷🪷🪷 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ogxpkivsz/">
    
    
    
    
    
      
    
    就很喜欢这些奇奇怪怪大儿童，以及女娲都补不了的大脑洞<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@张怡微<!-- raw HTML omitted -->: 🪷🪷🪷 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/Oh1j4zxzL">聊得很开心，且最后大家看过的故事都连成一片。沈瑞欣说，原来《后翼弃兵》中贝丝每次赛前服用的绿色小药丸就是亚瑟·萨克勒早年经手的利眠宁。《疼痛帝国》中提...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-oh1j4zxzl/">
    
    
    
    
    
      
    
    聊得很开心，且最后大家看过的故事都连成一片。沈瑞欣说，原来《后翼弃兵》中贝丝每次赛前服用的绿色小药丸就是亚瑟·萨克勒早年经手的利眠宁。《疼痛帝国》中提到的《梦瘾》、《止痛毒丸》也都引进出版了，与剧集《成瘾计量》、《无痛杀手》、纪录片《药剂师》、《所有的美丽与血泪》对读，可看到非虚 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/62b0d24fly1hqa64haybuj20u014016v.jpg%22">https://tvax1.sinaimg.cn/large/62b0d24fly1hqa64haybuj20u014016v.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3DKz9GN">🔻这不是真正的球迷。🔻图2才是真正的球迷。#欧冠决赛# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3dkz9gn/">
    
    
    
    
    
      
    
    🔻这不是真正的球迷。<!-- raw HTML omitted -->🔻图2才是真正的球迷。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#欧冠决赛#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3mCCxQn">如果我没有看错的话，你是在责怪我们没有干涉墨西哥内政和在墨西哥驻军？[哆啦A梦吃惊]//@卡塔昌一般树:所以你看，你不去保护你的海外利益，你的海外资产就是别...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3mccxqn/">
    
    
    
    
    
      
    
    如果我没有看错的话，你是在责怪我们没有干涉墨西哥内政和在墨西哥驻军？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@卡塔昌一般树<!-- raw HTML omitted -->:所以你看，你不去保护你的海外利益，你的海外资产就是别人的提款机<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻多说两句，墨西哥现任总统 AMLO &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3mZmJiK">“那能一样吗？”//@心脑袋:其实就很简单了，正着想不明白，反过来想就是了。外国企业在咱们这经商，你乐意人家持剑经商不？ - 转发 @包容万物恒河水:&amp;ensp;🔻...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3mzmjik/">
    
    
    
    
    
      
    
    “那能一样吗？”//<!-- raw HTML omitted -->@心脑袋<!-- raw HTML omitted -->:其实就很简单了，正着想不明白，反过来想就是了。外国企业在咱们这经商，你乐意人家持剑经商不？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻帝国主义的日子不好过。不要羡慕帝国主义。<!-- raw HTML omitted -->🔻帝国主义的大公司，现在也是在全世界靠交赎金、花公关费、请律师团、上下打点、高端低端商战一起来、有时甚至还要卖勾子做的生意，有些人幻想中的那个伪装成公司的实体叫东印度公司，死好多年了。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3nN83jY">给你推荐两本小说，很多年前完本了，叫《叛徒》和《逍遥军医》，我熟人重庆的老五写的，讲的就是你说的内容，去看吧，很爽，一些情节在现在的地缘政治中竟然得到...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3nn83jy/">
    
    
    
    
    
      
    
    给你推荐两本小说，很多年前完本了，叫《叛徒》和《逍遥军医》，我熟人重庆的老五写的，讲的就是你说的内容，去看吧，很爽，一些情节在现在的地缘政治中竟然得到了印证。//<!-- raw HTML omitted -->@J_has_Image<!-- raw HTML omitted -->:但是我好想我们国家的雇佣兵全世界收战争赔款<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3tWAEzR">🔻克洛普乐在其中🤣 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3twaezr/">
    
    
    
    
    
      
    
    🔻克洛普乐在其中🤣 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/uae9G1Y6lx08fk5nFAfK01041200cy4u0E010.mp4?labe">https://f.video.weibocdn.com/o0/uae9G1Y6lx08fk5nFAfK01041200cy4u0E010.mp4?labe</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3vArRns">🔻“今天的巴萨球迷” [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3varrns/">
    
    
    
    
    
      
    
    🔻“今天的巴萨球迷” <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/yC3">https://f.video.weibocdn.com/o0/yC3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3wribRD">🔻表情包发完了，睡觉。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3wribrd/">
    
    
    
    
    
      
    
    🔻表情包发完了，睡觉。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh3zfCsBB">我是曼联球迷，我为什么要看欧冠决赛//@KD35Messi10:欧冠决赛不看了 - 转发 @包容万物恒河水:&amp;ensp;🔻表情包发完了，睡觉。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh3zfcsbb/">
    
    
    
    
    
      
    
    我是曼联球迷，我为什么要看欧冠决赛//<!-- raw HTML omitted -->@KD35Messi10<!-- raw HTML omitted -->:欧冠决赛不看了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻表情包发完了，睡觉。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh43ftfLp">🔻仅次于曼联的最佳球迷。#欧冠决赛# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh43ftflp/">
    
    
    
    
    
      
    
    🔻仅次于曼联的最佳球迷。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#欧冠决赛#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oh4bF0XNM">🔻[哆啦A梦吃惊]#欧冠决赛# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oh4bf0xnm/">
    
    
    
    
    
      
    
    🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#欧冠决赛#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinai">https://tvax1.sinai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgX5y4KOs">今天儿童节，中学群和大学群的老儿童们都在互祝节日快乐[鲜花]我在大三的时候，曾写过一篇有点凄迷的短文《童心》，发表在校报上，其中一节云：“当我们白发如雪...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogx5y4kos/">
    
    
    
    
    
      
    
    今天儿童节，中学群和大学群的老儿童们都在互祝节日快乐<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->我在大三的时候，曾写过一篇有点凄迷的短文《童心》，发表在校报上，其中一节云：“当我们白发如雪、两眼昏花的时候，还能怀有一颗童心吗？我的朋友说，如果一个人没有了孩子的天真，留下的就全是坏心眼。”我现在虽然没有白发如雪，两眼也没有昏花，但毋庸讳言，人老了，不可能有孩子的天真，但留下的全是坏心眼吗？呵呵，自己骂自己，真是岂有此理！一笑。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9mw03sy9j20k00zkwj9.jpg%22">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9mw03sy9j20k00zkwj9.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgXTvsLDV">东园食堂可能是江安校区最差的食堂，菜做得太粗糙了，难怪南门外的大排档餐馆天天都那么火爆。唯一优势，价格比外面餐馆便宜一点，毛血旺10元，咸烧白8元，藕3元...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogxtvsldv/">
    
    
    
    
    
      
    
    东园食堂可能是江安校区最差的食堂，菜做得太粗糙了，难怪南门外的大排档餐馆天天都那么火爆。唯一优势，价格比外面餐馆便宜一点，毛血旺10元，咸烧白8元，藕3元，豆腐3元，米饭2元。喵奶奶说你不要在微博上东写西写，我说我就是要写，她说人家又把你拿来禁言！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9qm">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq9qm</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgYDa6Hpm">著名教育家、语文特级教师李镇西老师三年前的“六一宣言”：保卫儿童！【李镇西】保卫儿童！——我的《六一宣言》</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogyda6hpm/">
    
    
    
    
    
      
    
    著名教育家、语文特级教师李镇西老师三年前的“六一宣言”：保卫儿童！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->【李镇西】保卫儿童！——我的《六一宣言》<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oh2bWu2cn">今天逞口舌之快，吐槽四川大学江安校区东园食堂，实属忘记初心。大学是求知的地方，不是享受的地方。我青年求知时代，本科北京钢院，硕士四川师大，博士北京师大...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oh2bwu2cn/">
    
    
    
    
    
      
    
    今天逞口舌之快，吐槽四川大学江安校区东园食堂，实属忘记初心。大学是求知的地方，不是享受的地方。我青年求知时代，本科北京钢院，硕士四川师大，博士北京师大，学生食堂都不可能与川大江安校区的东园食堂比。但我个人认为，必须比，与我们这代人的大学食堂比，才能比出今天的幸福。 先比本科食堂。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgXF8w1O1">笑死了，笑话原来还能升级[赞]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogxf8w1o1/">
    
    
    
    
    
      
    
    笑死了，笑话原来还能升级<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgYzYxbrI">转发微博 - 转发 @ResonationNmA:&amp;ensp;2024LPL夏季赛宣传片中的围棋。[笑哈哈] [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogyzyxbri/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@ResonationNmA<!-- raw HTML omitted -->: 2024LPL夏季赛宣传片中的围棋。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinai">https://tvax4.sinai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgXOCg9xS">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里【BLOG】24/05/31 「青春って嬉しくて素晴らしくて美味しいね」翻译稍后 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogxocg9xs/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->【BLOG】24/05/31 <!-- raw HTML omitted -->「青春って嬉しくて素晴らしくて美味しいね」<!-- raw HTML omitted -->翻译稍后 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sina">https://tvax4.sina</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgYza1GcT">🥹//@角煮弁当:😭//@废话巨多R :😎//@烤球局长 :[裂开]//@大豆田跑跑子与前三个号 :😰//@无表情炸鸡 :想她 - 转发 @暁Mizuki:&amp;ensp;分享圖片 [图片][图...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogyza1gct/">
    
    
    
    
    
      
    
    🥹//<!-- raw HTML omitted -->@角煮弁当<!-- raw HTML omitted -->:😭//<!-- raw HTML omitted -->@废话巨多R<!-- raw HTML omitted --> :😎//<!-- raw HTML omitted -->@烤球局长<!-- raw HTML omitted --> :<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@大豆田跑跑子与前三个号<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0fCtohZ">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 青春って嬉しくて素晴らしくて美味しいね 【BLOG】24/05/31青春真是让人高兴 、 美好又美味呢 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0fctohz/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://weibo.com/ttarticle/p/show?id=2309405040498359533989%22">https://weibo.com/ttarticle/p/show?id=2309405040498359533989&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0fyeDIZ">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.06.01 16:26「卷卷」最近，迷上了波浪头 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0fyediz/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh0z61iOk">怎么不算吃了织儿代言的产品（ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh0z61iok/">
    
    
    
    
    
      
    
    怎么不算吃了织儿代言的产品（ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh35P03da">我有一只麦兜小猪十岁那年生日姐姐买给我的那会儿是2010年姐姐那天下午下课早骑着电动车载着我去了县里边最早开业的杂货商场我也不记得为什么去了一家挂满玩偶的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh35p03da/">
    
    
    
    
    
      
    
    我有一只麦兜小猪<!-- raw HTML omitted -->十岁那年生日姐姐买给我的<!-- raw HTML omitted -->那会儿是2010年<!-- raw HTML omitted -->姐姐那天下午下课早<!-- raw HTML omitted -->骑着电动车载着我去了县里边最早开业的杂货商场<!-- raw HTML omitted -->我也不记得为什么去了一家挂满玩偶的店<!-- raw HTML omitted -->但一定是我和姐姐说过我想要<!-- raw HTML omitted -->那会儿应该是麦兜电影上线了所以我选择了小猪<!-- raw HTML omitted -->店家一开始开口说七八十<!-- raw HTML omitted -->姐姐砍了价砍到四十买下了<!-- raw HTML omitted -->年纪很小，并不知道那个时候这样的价钱意味着什么<!-- raw HTML omitted -->今晚我妈说路边卖的玩偶都很劣质劝我们不要买<!-- raw HTML omitted -->妹妹朗声告诉她我床上的这些都很贵<!-- raw HTML omitted -->我就想起来我的小猪<!-- raw HTML omitted -->突然意识到2010年的物价，40块真的很贵<!-- raw HTML omitted -->虽然小猪确实是我所拥有的这些小宝贝们里最便宜的<!-- raw HTML omitted -->但是是我永远最贵重的<!-- raw HTML omitted -->好多年里我妈几次就想丢了，要么我自己拦下了<!-- raw HTML omitted -->要么妹妹帮我拦下了<!-- raw HTML omitted -->这一两年妈妈也学会尊重我们的想法<!-- raw HTML omitted -->没有再提过要丢掉的事情<!-- raw HTML omitted -->我还有一只特别喜欢的小熊<!-- raw HTML omitted -->就是我经常说想 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oh3dKeaoT">感谢亲爹提携🥹🫰🏻 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里 麦当劳麦辣鸡块CM摄影后采访 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oh3dkeaot/">
    
    
    
    
    
      
    
    感谢亲爹提携🥹🫰🏻<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->麦当劳麦辣鸡块CM摄影后采访 <!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5040590421688351%22">https://video.weibo.com/show?fid=1034:5040590421688351&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgXLyxG4D">久保史绪里【BLOG】24/05/31 「青春って嬉しくて素晴らしくて美味しいね」翻译稍后 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogxlyxg4d/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->【BLOG】24/05/31 <!-- raw HTML omitted -->「青春って嬉しくて素晴らしくて美味しいね」<!-- raw HTML omitted -->翻译稍后 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgXONkZjM">再增加一张//@顶筆TEN使:增加一张 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木のの&amp;乃木坂46 X [图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogxonkzjm/">
    
    
    
    
    
      
    
    再增加一张//<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:增加一张<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木のの&amp;乃木坂46 X &lt;img  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgZ2gCVBX">久保史绪里#久保史绪里手机博# 2024.06.01 16:26「卷卷」最近，迷上了波浪头 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogz2gcvbx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgZxWcTKF">久保史绪里 青春って嬉しくて素晴らしくて美味しいね 【BLOG】24/05/31青春真是让人高兴 、 美好又美味呢 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogzxwctkf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09">https://h5.sinaimg.cn/upload/2015/09</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oh20b3Oli">久保史绪里 麦当劳麦辣鸡块CM摄影后采访 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oh20b3oli/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->麦当劳麦辣鸡块CM摄影后采访 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/20">https://h5.sinaimg.cn/upload/20</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oh11mB4bE">儿童节快乐[赢牛奶] - 转发 @棋士柯洁:&amp;ensp;玩了一整天游戏，儿童节过得很充实😌祝各位大宝宝小宝宝们六一儿童节快乐！</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oh11mb4be/">
    
    
    
    
    
      
    
    儿童节快乐<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@棋士柯洁<!-- raw HTML omitted -->: 玩了一整天游戏，儿童节过得很充实😌祝各位大宝宝小宝宝们六一儿童节快乐！ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701074460">量子位发表了文章: ControlNet作者搞起大模型：让天下没有难写的生图提示词，一句话变构图小作文</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701074460/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701077714">量子位发表了文章: 六位一线AI工程师总结爆火：大模型应用摸爬滚打一年心得公开</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701077714/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701078941">量子位发表了文章: AI读论文新神器：多栏密集文字、中英图文混排文档都能读｜旷视</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701078941/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701084774">量子位发表了文章: 首个智慧城市大模型UrbanGPT，全面开源开放｜港大&amp;百度</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-01</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701084774/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://github.com/521xueweihan/HelloGitHub/blob/master/content/HelloGitHub98.md">《HelloGitHub》第 98 期</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/github-com-521xueweihan-hellogithub-blob-master-content-hellogithub98-md/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38816992/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38816992-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Pain and physical functioning as subdomains of QoL are improved after RAPN compared to OPN in the early postoperative course, while there are no differences anymore after 3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38816992/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Quality-of-life outcomes of the ROBOtic-assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38816992-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Pain and physical functioning as subdomains of QoL are improved after RAPN compared to OPN in the early postoperative course, while there are no differences anymore after 3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817595/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817595-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background With more effective therapies for patients with advanced breast cancer (aBC), therapy sequences are becoming increasingly important. However, some patients might drop out of the treatment sequence due to deterioration of their life status. Since little is known about attrition in the real-world setting, this study assessed attrition in the first three therapy lines using a real-world registry. Methods Patients with information available on the first three therapy lines were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817595/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817595-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background With more effective therapies for patients with advanced breast cancer (aBC), therapy sequences are becoming increasingly important. However, some patients might drop out of the treatment sequence due to deterioration of their life status. Since little is known about attrition in the real-world setting, this study assessed attrition in the first three therapy lines using a real-world registry. Methods Patients with information available on the first three therapy lines were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817598/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817598-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In recent years, new targeted therapies have been developed to treat patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Some of these therapies have not just become the new therapy standard but also led to significantly longer overall survival rates. The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have become the therapeutic standard for first-line therapy. Around 70 - 80% of patients are treated with a CDK4/6i. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38817598/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38817598-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In recent years, new targeted therapies have been developed to treat patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Some of these therapies have not just become the new therapy standard but also led to significantly longer overall survival rates. The cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) have become the therapeutic standard for first-line therapy. Around 70 - 80% of patients are treated with a CDK4/6i. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Unintentional injuries and falls in populations in Russia. The Ural eye and medical study and the Ural very old study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: UIFs have occurred to a substantial part of the adult and very old population in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Unintentional injuries and falls in populations in Russia. The Ural eye and medical study and the Ural very old study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: UIFs have occurred to a substantial part of the adult and very old population in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818593/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Do Physicians Have a Duty to Support Secondary Use of Clinical Data in Biomedical Research? An Inquiry into the Professional Ethics of Physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818593-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Secondary use of clinical data in research or learning activities (SeConts) has the potential to improve patient care and biomedical knowledge. Given this potential, the ethical question arises whether physicians have a professional duty to support SeConts. To investigate this question, we analyze prominent international declarations on physicians' professional ethics to determine whether they include duties that can be considered as good reasons for a physicians' professional duty to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38818593/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Do Physicians Have a Duty to Support Secondary Use of Clinical Data in Biomedical Research? An Inquiry into the Professional Ethics of Physicians</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38818593-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Secondary use of clinical data in research or learning activities (SeConts) has the potential to improve patient care and biomedical knowledge. Given this potential, the ethical question arises whether physicians have a professional duty to support SeConts. To investigate this question, we analyze prominent international declarations on physicians' professional ethics to determine whether they include duties that can be considered as good reasons for a physicians' professional duty to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Microglia: a promising therapeutic target in spinal cord injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Microglia are present throughout the central nervous system and are vital in neural repair, nutrition, phagocytosis, immunological regulation, and maintaining neuronal function. In a healthy spinal cord, microglia are accountable for immune surveillance, however, when a spinal cord injury occurs, the microenvironment drastically changes, leading to glial scars and failed axonal regeneration. In this context, microglia vary their gene and protein expression during activation, and proliferation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819048/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Microglia: a promising therapeutic target in spinal cord injury</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819048-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Microglia are present throughout the central nervous system and are vital in neural repair, nutrition, phagocytosis, immunological regulation, and maintaining neuronal function. In a healthy spinal cord, microglia are accountable for immune surveillance, however, when a spinal cord injury occurs, the microenvironment drastically changes, leading to glial scars and failed axonal regeneration. In this context, microglia vary their gene and protein expression during activation, and proliferation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">S100A1&#39;s single cysteine is an indispensable redox-switch for the protection against diastolic calcium wavesin cardiomyocytes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The EF-hand calcium (Ca^(2+)) sensor protein S100A1 combines inotropic with antiarrhythmic potency in cardiomyocytes (CM). Oxidative posttranslational modification (ox-PTM) of S100A1&rsquo;s conserved, single cysteine residue (C85) via reactive nitrogen species (i.e. S-nitrosylation or glutathionylation) has been proposed to modulate conformational flexibility of intrinsically disordered sequence fragments and to increase the molecule&rsquo;s affinity towards Ca^(2+). In light of the unknown &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">S100A1&#39;s single cysteine is an indispensable redox-switch for the protection against diastolic calcium wavesin cardiomyocytes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The EF-hand calcium (Ca^(2+)) sensor protein S100A1 combines inotropic with antiarrhythmic potency in cardiomyocytes (CM). Oxidative posttranslational modification (ox-PTM) of S100A1&rsquo;s conserved, single cysteine residue (C85) via reactive nitrogen species (i.e. S-nitrosylation or glutathionylation) has been proposed to modulate conformational flexibility of intrinsically disordered sequence fragments and to increase the molecule&rsquo;s affinity towards Ca^(2+). In light of the unknown &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">Efficacy and Safety of Donidalorsen for Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Donidalorsen treatment reduced the hereditary angioedema attack rate, a finding that supports potential prophylactic use for hereditary angioedema. (Funded by Ionis Pharmaceuticals; OASIS-HAE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Efficacy and Safety of Donidalorsen for Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Donidalorsen treatment reduced the hereditary angioedema attack rate, a finding that supports potential prophylactic use for hereditary angioedema. (Funded by Ionis Pharmaceuticals; OASIS-HAE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Nimodipine as Vasodilator in Guide Catheter Flush to Prevent Vasospasm During Endovascular Stroke Treatment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Prophylactic adding of nimodipine reduces the risk of vasospasm during EVT without affecting the clinical outcome. Patients with anterior circulation TVO experienced more vasospasm compared to posterior circulation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">New Therapies for Type 1 and Type 2 Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">New Therapies for Type 1 and Type 2 Hereditary Angioedema</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819658/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240531182133&amp;v=2.18.0.post9&#43;e462414">Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819658-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240531182133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and complete attack resolution than placebo. (Funded by KalVista Pharmaceuticals; KONFIDENT ClinicalTrials.gov number, NCT05259917; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819658/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819658-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and complete attack resolution than placebo. (Funded by KalVista Pharmaceuticals; KONFIDENT ClinicalTrials.gov number, NCT05259917; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819686/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Deficit of trainees in thoracic surgery : Do we need to adapt or become extinct?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819686-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Students know exactly what they want for their future and where surgery has its weaknesses. They want transparent and practical training, a work-life balance, and recognition of their work and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819686/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Deficit of trainees in thoracic surgery : Do we need to adapt or become extinct?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819686-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Students know exactly what they want for their future and where surgery has its weaknesses. They want transparent and practical training, a work-life balance, and recognition of their work and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240531182159&amp;v=2.18.0.post9&#43;e462414">Retraction Note: Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240531182159-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Retraction Note: Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819930/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Determination of energetic positions of electronic states and the exciton dynamics in a π-expanded N-heterotriangulene derivative adsorbed on Au(111)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819930-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Bridged triarylamines, so-called N-heterotriangulenes (N-HTAs) are promising organic semiconductors for applications in optoelectronic devices. Thereby the electronic structure at organic/metal interfaces and within thin films as well as the electronically excited states dynamics after optical excitation is essential for the performance of organic-molecule-based devices. Here, we investigated the energy level alignment and the excited state dynamics of a N-HTA derivative adsorbed on Au(111) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38819973/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240601181229&amp;v=2.18.0.post9&#43;e462414">A Vision Transformer-Based Framework for Knowledge Transfer From Multi-Modal to Mono-Modal Lymphoma Subtyping Models</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38819973-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240601181229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Determining lymphoma subtypes is a crucial step for better patient treatment targeting to potentially increase their survival chances. In this context, the existing gold standard diagnosis method, which relies on gene expression technology, is highly expensive and time-consuming, making it less accessibility. Although alternative diagnosis methods based on IHC (immunohistochemistry) technologies exist (recommended by the WHO), they still suffer from similar limitations and are less &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820078/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240601181228&amp;v=2.18.0.post9&#43;e462414">Asciminib in Newly Diagnosed Chronic Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820078-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240601181228-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this trial comparing asciminib with investigator-selected TKIs and imatinib, asciminib showed superior efficacy and a favorable safety profile in patients with newly diagnosed chronic-phase CML. Direct comparison between asciminib and second-generation TKIs was not a primary objective. (Funded by Novartis; ASC4FIRST ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820118/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Serum IgG antibodies to HPV6 L1, E2, E4, E6, and E7 proteins among children prospectively followed-up for three years</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820118-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: IgG antibodies against HPV6 E- and L-proteins are transferred from mothers to their children. Seroconversion against HPV6 L1, E2, E4, E6, and E7 does occur in early childhood, as a sign of acquired HPV6 infection by vertical or horizontal transmission starting at 12 months of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820372/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820372-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is an urgent need for rapid, non-sputum point-of-care diagnostics to detect tuberculosis. This prospective trial in seven high tuberculosis burden countries evaluated the diagnostic accuracy of the point-of-care urine-based lipoarabinomannan assay FUJIFILM SILVAMP TB LAM (FujiLAM) among inpatients and outpatients living with HIV. Diagnostic performance of FujiLAM was assessed against a mycobacterial reference standard (sputum culture, blood culture, and Xpert Ultra from urine and sputum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820491/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Venovenous bypass in adult liver transplant recipients: A single-center observational case series</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820491-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: VVB continues to play a vital role in LT. This case series highlights the heightened risk of major complications linked to VVB. However, the global transition to selective use of VVB underscores the urgent need for collaborative multi-center studies designed to address outstanding questions and parameters related to the safe implementation of this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820498/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">4D intravital imaging identifies platelets as the predominant cellular procoagulant surface in a mouse hemostasis model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820498-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Interplay between platelets, coagulation factors, endothelial cells (ECs) and fibrinolytic factors is necessary for effective hemostatic plug formation. This study describes a four-dimensional (4D) imaging platform to visualize and quantify hemostatic plug components in mice with high spatiotemporal resolution. Fibrin accumulation following laser-induced vascular injury was observed at the platelet plug-EC interface, controlled by the antagonistic balance between fibrin generation and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820500/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Randomized Bendamustine-Rituximab(R) &#43; Bortezomib Induction and R &#43; Lenalidomide Maintenance for Mantle Cell Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820500-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    While initial therapy of mantle cell lymphoma (MCL) is not standardized, bendamustine-rituximab (BR) is commonly used in older patients. Rituximab (R) maintenance following induction is often utilized. Thus, the open-label, randomized phase II ECOG-ACRIN Cancer Research Group E1411 trial was designed to test two questions: 1) Does addition of bortezomib to BR induction (BVR) and/or 2) addition of lenalidomide to rituximab (LR) maintenance improve progression-free survival (PFS) in patients &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820503/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Exceptional Response of &lt;em&gt;BRAF&lt;/em&gt;&lt;sup&gt;V600E&lt;/sup&gt;-Mutated Acinar Cell CUP to BRAF/MEK Inhibition</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820503-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Complete remission of BRAF V600E-driven ACC CUP by BRAF/MEK inhibition underscores importance of precision &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820588/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">NOVEL THERAPEUTIC APPROACHES IN THALASSEMIAS, SICKLE CELL DISEASE AND OTHER RED CELL DISORDERS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820588-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In this last decade, a deeper understanding of the pathophysiology of hereditary red cell disorders and the development of novel classes of pharmacologic agents have provided novel therapeutic approaches to thalassemias, sickle cell disease (SCD) and other red cell disorders. Here, we analyze and discuss the novel therapeutic options according to their targets and taking into consideration the complex process of erythroid differentiation, maturation, and survival of erythrocytes in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820589/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Heme induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820589-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Chronic kidney disease (CKD) is a major contributor to morbidity and mortality in sickle cell disease (SCD). Anemia, induced by chronic persistent hemolysis, is associated with progressive deterioration of renal health resulting in CKD. Moreover, patients with SCD experience acute kidney injury (AKI), a risk factor for CKD, often during vasoocclusive crisis associated with acute intravascular hemolysis. However, the mechanisms of the hemolysis-driven pathogenesis of the AKI-to-CKD transition &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820590/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Interleukin-1 mediated hyperinflammation in XIAP-deficiency is associated with defective autophagy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820590-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Deficiency of X-linked Inhibitor of Apoptosis Protein (XIAP) is a rare genetic condition that can present with recurrent episodes of hemophagocytic lymphohistiocytosis (HLH), though the exact mechanisms leading to this hyperinflammatory disorder are unclear. Understanding its biology is critical to developing targeted therapies for this potentially fatal disease. Here we report on a novel multi-exonic intragenic duplication leading to XIAP deficiency with recurrent HLH that demonstrated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820591/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240601181226&amp;v=2.18.0.post9&#43;e462414">Cardiac complete response in AL amyloidosis has similar survival to matched general population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820591-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240601181226-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The survival of patients achieving a cardiac complete response in AL amyloidosis, defined as NT-proBNP ≤350 pg/mL or BNP ≤80 pg/mL, was similar to a matched general population with an estimated 5-year survival rate of 93% vs 95%, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820608/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Robotic thoracic surgery for neurogenic tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820608-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: RATS for thoracic neurogenic tumors is feasible and safe. Tumors at the thoracic apex are at high risk of neurological deficit and should be approached with care. Close interdisciplinary collaboration between neurosurgeons and thoracic surgeons is necessary for optimal patient selection and a good postoperative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820715/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240601181018&amp;v=2.18.0.post9&#43;e462414">Masked hypergraph learning for weakly supervised histopathology whole slide image classification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820715-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240601181018-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: MaskHGL shows a great improvement, brought by considering the intrinsic non-pairwise relationships within WSI, in multiple downstream WSI classification tasks. In particular, the designed masked hypergraph reconstruction module promisingly alleviates the data scarcity and greatly enhances the robustness and classification ability of our MaskHGL. Notably, it has shown great potential in cancer subtyping and fine-grained lung cancer gene mutation prediction from hematoxylin and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38820910/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Targeted mutational profiling of Epstein Barr virus-positive mucocutaneous ulcer: Implications for differential diagnosis with EBV-positive diffuse large B-cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38820910-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epstein Barr Virus-positive mucocutaneous ulcer (EBVMCU) can be difficult to distinguish from EBV-positive diffuse large B cell lymphoma (DLBCL). We used targeted next-generation sequencing (NGS) to explore genetic alterations in EBVMCU to aid in this diagnostic challenge. Ten cases of EBVMCU were evaluated by a targeted NGS panel of 164 genes. Targeted NGS identified 18 variants in 15 genes in eight cases of EBVMCU. Loss of function TET2 variants were most frequently identified (3 of 10 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821062/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821062-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cellular mechanisms mediating immunotherapy resistances are incompletely understood. In this issue, Li et al. reveal how breast cancer hijacks neuronal mechanisms of neuroprotection to shield itself from the immune system. Secretion of N-acetylaspartate impairs immune synapse formation in both neuroinflammation and breast cancer models, paving the way for novel therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821074/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821074-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chimeric antigen receptor (CAR) T-cell therapy has shown promise in patients with late-line refractory multiple myeloma, with response rates ranging from 73 to 98%. To date, three products have been approved: Idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel), which are approved by the US Food and Drug Administration, the European Medicines Agency, Health Canada (ide-cel only), and Brazil ANVISA (cilta-cel only); and equecabtagene autoleucel (eque-cel), which was &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821932/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240601181254&amp;v=2.18.0.post9&#43;e462414">Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821932-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240601181254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like protein 1 (Aplp1) interacts with Lag3 that facilitates the binding, internalization, transmission, and toxicity of pathologic α-syn. Deletion of both Aplp1 and Lag3 eliminates the loss of dopaminergic neurons and the accompanying behavioral deficits induced by α-syn preformed fibrils (PFF). Anti-Lag3 prevents &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38821935/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240601181045&amp;v=2.18.0.post9&#43;e462414">Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38821935-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240601181045-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however, often show advanced stage, progression to T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and a worse prognosis. We studied the tumor microenvironment (TME) of NLPHL and THRLBCL using highplex imaging and spatial profiling at the single cell level. Our findings show distinct differences in TME composition and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgNRZ3X6l">在新冠疫情中和长新冠（Long COVID/PASC）研究中做出了卓越贡献（网页链接）的St Louis VA在今天上线的Nature Med上发表了一项十分重要的长新冠队列研究，报道了...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ognrz3x6l/">
    
    
    
    
    
      
    
    在新冠疫情中和长新冠（Long COVID/PASC）研究中做出了卓越贡献（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）的St Louis VA在今天上线的Nature Med上发表了一项十分重要的长新冠队列研究，报道了感染SARS-CoV-2后随访3年患者发生PASC的情况。在感染SARS-CoV-2后的非住院患者中，在感染SARS-CoV-2一年后，患者全因死亡风险并未增加，但SARS-CoV-2感染后造成长新冠从而影响工作、生活（DALYs）发 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgPf1p2K7">本月Bill Schief组一连在Science和子刊发表了4篇HIV疫苗研究论文（网页链接），引起了巨大反响；今天上线的Nature Immunology发表了该组另一项最新的HIV疫苗研究...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogpf1p2k7/">
    
    
    
    
    
      
    
    本月Bill Schief组一连在Science和子刊发表了4篇HIV疫苗研究论文（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->），引起了巨大反响；今天上线的Nature Immunology发表了该组另一项最新的HIV疫苗研究工作，这项研究与Haynes组刚刚发表的论文（<!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OgUNj77qU">FDA今天批准了Moderna的RSV疫苗用于60岁以上人群接种。这是第三个被批准的RSV疫苗。其在NEJM发表的临床试验结果显示其有效性为83.7%（网页链接）；但其持久性可...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ogunj77qu/">
    
    
    
    
    
      
    
    FDA今天批准了Moderna的RSV疫苗用于60岁以上人群接种。这是第三个被批准的RSV疫苗。其在NEJM发表的临床试验结果显示其有效性为83.7%（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）；但其持久性可能比GSK RSV疫苗略低（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn">https://h5.sinaimg.cn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OgOkabVBO">借书评来做植物科普，真是一大发明 - 转发 @天冬:&amp;ensp;#天冬博物日志# 这是一条长微博，来说说@马伯庸 《食南之徒》里的植物。早早就买了亲王马伯庸的新书《食...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ogokabvbo/">
    
    
    
    
    
      
    
    借书评来做植物科普，真是一大发明<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@天冬<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#天冬博物日志#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSF0gBvb">🔻“谁说骑士精神已死？” 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogsf0gbvb/">
    
    
    
    
    
      
    
    🔻“谁说骑士精神已死？” <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/dPFuZ4dalx08fifRzfsk010412003o2y0E010.m">https://f.video.weibocdn.com/o0/dPFuZ4dalx08fifRzfsk010412003o2y0E010.m</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSHefcbE">🔻目前为止，还没有艾森豪威尔号情况的具体消息。🔻我估计，以现在也门这个打击密度，要想让这个战斗群的防空网饱和并且过载，还是有难度的，也门也没有尽全...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogshefcbe/">
    
    
    
    
    
      
    
    🔻目前为止，还没有艾森豪威尔号情况的具体消息。<!-- raw HTML omitted -->🔻我估计，以现在也门这个打击密度，要想让这个战斗群的防空网饱和并且过载，还是有难度的，也门也没有尽全力。<!-- raw HTML omitted -->🔻现在 CVN-69 的位置，是根据两架格鲁曼 C-2 灰狗往返的航迹确定的。<!-- raw HTML omitted -->🔻至少目前灰狗还在飞。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#艾森豪威尔号航母#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbly1hq93zf72fqj20u01gj4qp.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbly1hq93zf72fqj20u01gj4qp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSHu5ZTP">🔻明显感觉到了世界变局的加速度。#中方确认不参加乌克兰问题和平峰会# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogshu5ztp/">
    
    
    
    
    
      
    
    🔻明显感觉到了世界变局的加速度。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#中方确认不参加乌克兰问题和平峰会#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hq944e9eogj20hp0q7n40.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hq944e9eogj20hp0q7n40.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSLC5kkm">🔻立陶宛外交部长不排除乌克兰可能对白俄罗斯领土发动袭击，立陶宛外交部长加布里埃利乌斯·兰茨贝吉斯对媒体表示，乌克兰有权打击白俄罗斯境内的俄罗斯军事目...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogslc5kkm/">
    
    
    
    
    
      
    
    🔻立陶宛外交部长不排除乌克兰可能对白俄罗斯领土发动袭击，立陶宛外交部长加布里埃利乌斯·兰茨贝吉斯对媒体表示，乌克兰有权打击白俄罗斯境内的俄罗斯军事目标。<!-- raw HTML omitted -->🔻via 塔斯社<!-- raw HTML omitted -->🔻波三小真的是。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSSDkMRY">🔻网友提醒：广州沥心沙大桥的修复工作已经进入最后收尾工程，恢复通车指日可待。🔻[哆啦A梦吃惊]，这才多久？🔻via @广州南沙发布 公众号 包容万物恒河水...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogssdkmry/">
    
    
    
    
    
      
    
    🔻网友提醒：广州沥心沙大桥的修复工作已经进入最后收尾工程，恢复通车指日可待。<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->，这才多久？<!-- raw HTML omitted -->🔻via <!-- raw HTML omitted -->@广州南沙发布<!-- raw HTML omitted --> 公众号 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSSVablE">🔻印度那格浦尔的气温为 56 摄氏度。🔻[哆啦A梦害怕] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogssvable/">
    
    
    
    
    
      
    
    🔻印度那格浦尔的气温为 56 摄氏度。<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSTc6lZW">🔻斯托尔滕贝格提议北约成员国每年向乌克兰支付 400 亿美元。🔻如果他们能为自己的人民引导这种能量，那就太好了。🔻via vk/smotri_media 包容万物恒河水...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogstc6lzw/">
    
    
    
    
    
      
    
    🔻斯托尔滕贝格提议北约成员国每年向乌克兰支付 400 亿美元。<!-- raw HTML omitted -->🔻如果他们能为自己的人民引导这种能量，那就太好了。<!-- raw HTML omitted -->🔻via vk/smotri_media <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq94xo6i84j21hc0u0dhh.jpg%22">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hq94xo6i84j21hc0u0dhh.jpg&quot;</a> style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgSYa8exI">🔻晚安。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogsya8exi/">
    
    
    
    
    
      
    
    🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgTtakUdV">🔻艾森豪威尔号的舰长 Chowdah Hill 刚刚在自己的账号上更新了舰上的厨房。🔻看来，可能没有造成足够的威胁。#艾森豪威尔号航母# [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogttakudv/">
    
    
    
    
    
      
    
    🔻艾森豪威尔号的舰长 Chowdah Hill 刚刚在自己的账号上更新了舰上的厨房。<!-- raw HTML omitted -->🔻看来，可能没有造成足够的威胁。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#艾森豪威尔号航母#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hq97i0">https://tvax4.sinaimg.cn/large/639b1bfbly1hq97i0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OgTznoF4j">不管大家信不信，也算是个阴阳怪气的回应吧。这舰长一贯挺阴阳的，好几次了。//@今今天不快樂:这就感觉故意此地无银的感觉[摊手] - 转发 @包容万物恒河水:&amp;ensp;...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ogtznof4j/">
    
    
    
    
    
      
    
    不管大家信不信，也算是个阴阳怪气的回应吧。这舰长一贯挺阴阳的，好几次了。//<!-- raw HTML omitted -->@今今天不快樂<!-- raw HTML omitted -->:这就感觉故意此地无银的感觉<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻艾森豪威尔号的舰长 Chowdah Hill 刚刚在自己的账号上更新了舰上的厨房。<!-- raw HTML omitted -->🔻看来，可能没有造成足够的威胁。<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%25">https://m.weibo.cn/search?containerid=231522type%3D1%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgNAGhVYl">6：20醒来，先假装陶渊明，视察雨后菜园，然后早餐，伏案工作，继续在《种豆得瓜集》扉页题词签名钤印，至9：30，完成152张，加上昨天晚上完成的50多张，已经过...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ognaghvyl/">
    
    
    
    
    
      
    
    6：20醒来，先假装陶渊明，视察雨后菜园，然后早餐，伏案工作，继续在《种豆得瓜集》扉页题词签名钤印，至9：30，完成152张，加上昨天晚上完成的50多张，已经过半。搁笔，更衣，正要出门，去小喵家当饲养员，上级来电，你今天可以不过来做晚饭了！喵爸说晚上买荣昌卤鹅，我再给他们煮两根香肠，炒一个素菜就行了。她说行不行？我说服从上级安排，她说好。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/d1840ee6gy1hq8gphrj6tj237k2eok">https://tvax3.sinaimg.cn/large/d1840ee6gy1hq8gphrj6tj237k2eok</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgOq6lIxS">本来想去吃教工食堂自助餐，但一出小区门，感觉天气太热，马上改变主意，到“俏江安”美食餐吧来解决午餐。美食太多，令人眼花缭乱，转了一大圈，最后选定陕西凉...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogoq6lixs/">
    
    
    
    
    
      
    
    本来想去吃教工食堂自助餐，但一出小区门，感觉天气太热，马上改变主意，到“俏江安”美食餐吧来解决午餐。美食太多，令人眼花缭乱，转了一大圈，最后选定陕西凉皮和新疆烤羊肉串。羊肉串味道尚可，但吃不出羊肉味，问烤肉人，你这是新疆羊肉吗？他说不是新疆羊肉，是宁夏滩羊。我说怎么吃不出羊肉味呢？他说宁夏滩羊没有膻味。我本来想说难道新疆羊肉有膻味？但如果他不顾事实，坚持说逗是，我也无法反驳他，就说你既然是新疆烤羊肉串，咋不用新疆羊肉？他说新疆太远了，进不来。我说成都就有一家新疆羊肉店，在抚琴路，可以送货上门，我家去年还买过几十斤。他就不言语了。我也不想和他争辩，反正今后我不会再来吃他的没有羊肉味的烤羊肉串了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq8jy10if5">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq8jy10if5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OgSv70ctG">从早到晚，都在为即将问世的《种豆得瓜集》题词、签名、钤印，没有后勤保障，午餐在小区外面的“俏江安美食吧”吃陕西凉皮和新疆烤宁夏羊肉串，都不满意。晚餐怎...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ogsv70ctg/">
    
    
    
    
    
      
    
    从早到晚，都在为即将问世的《种豆得瓜集》题词、签名、钤印，没有后勤保障，午餐在小区外面的“俏江安美食吧”吃陕西凉皮和新疆烤宁夏羊肉串，都不满意。晚餐怎么解决？<!-- raw HTML omitted --> 喵爷爷独立生活能力超强，发现冰箱有一个漏网的土豆，夕阳西下断肠人在天涯的时候，去菜园摘了几个二荆条辣椒，炒土豆丝。一菜一饭，是我们青少年时代的标配，喵爷爷吃得津津有味。<!-- raw HTML omitted --> 碗筷我是不会洗的，坚决不洗，因为洗碗工是喵奶奶承包了的。夫妻也应该有契约精神。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/d1840ee6gy1hq92n0q9tuj22bc334e8">https://tvax2.sinaimg.cn/large/d1840ee6gy1hq92n0q9tuj22bc334e8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgOtToqHQ">是这样的，对局的棋手只要全身心投入到棋局中，下出一选，奋力赢棋就可以，可是观战的键盘侠们要考虑的事情就很多了[doge]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogottoqhq/">
    
    
    
    
    
      
    
    是这样的，对局的棋手只要全身心投入到棋局中，下出一选，奋力赢棋就可以，可是观战的键盘侠们要考虑的事情就很多了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OgRwxrJl7">喝了一杯拿铁，感觉快睡着了[二哈]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ogrwxrjl7/">
    
    
    
    
    
      
    
    喝了一杯拿铁，感觉快睡着了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgNSywpaj">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.岡田准一 X信长时代的女儿久保史绪里桑的脸颊软乎乎的，很难下得了手去猛抓。因为当时是突然这样做的所以还以...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ognsywpaj/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.岡田准一 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgNV4nFnJ">转发微博 - 转发 @剑网3官方微博:&amp;ensp;不可思议，无界相逢！八大联动内容陪你共迎无界！线下线上大狂欢~侠士们准备好了嘛！转关抽5位侠士送上【613现金红包】，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ognv4nfnj/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@剑网3官方微博<!-- raw HTML omitted -->: 不可思议，无界相逢！八大联动内容陪你共迎无界！线下线上大狂欢~侠士们准备好了嘛！转关抽5位侠士送上【613现金红包】，评论区再抽5位幸运侠士送上【20000通宝】<!-- raw HTML omitted -->@微博抽奖平台<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->开始摇人啦！官博君为大家划联动重点啦 ↓<!-- raw HTML omitted -->● 办公无界，江湖相聚！WPS联动活动让办公与江湖都可以轻松畅游！<!-- raw HTML omitted -->● 喜提外卖，欢笑无界！剑网3 × 美团外卖 × DQ三方联动陪你度过清爽夏天！<!-- raw HTML omitted -->● 下天上海，相聚无界！巨型黄鸡大笑6月即将开启一场上海打卡巡游！<!-- raw HTML omitted -->● 大唐盛筵，番薯无界！剑网3携手非遗传人番薯玩家江寻千（九月）开启跨界的传承之旅！<!-- raw HTML omitted -->● 十五周年，乐享无界！十五周年盛典落地杭州小莲花！演唱会MIX &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgOfCowcT">转发微博 - 转发 @麦当劳:&amp;ensp;✍️看了内部资料，忍不住泄密：六一当天，买【20元20块麦乐鸡】，会触发神秘人物多送你一块！[嘘]#一块麦乐鸡一块多开心#🚫请...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogofcowct/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@麦当劳<!-- raw HTML omitted -->: ✍️看了内部资料，忍不住泄密：六一当天，买【20元20块麦乐鸡】，会触发神秘人物多送你一块！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B8%A1%E4%B8%80%E5%9D%97%E5%A4%9A%E5%BC%80%E5%BF%83%23&amp;amp;extparam=%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B8%A1%E4%B8%80%E5%9D%97%E5%A4%9A%E5%BC%80%E5%BF%83%23&amp;amp;extparam=%23%E4%B8%80%E5%9D%97%E9%BA%A6%E4%B9%90%E9%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgPKZ0uIj">转发微博 - 转发 @剑网3官方微博:&amp;ensp;侠士还记得2013年开启的“我为剑网3代言活动”吗？随着《剑网3》全平台上线的临近，全新激励回馈活动震撼来袭，这次就是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogpkz0uij/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@剑网3官方微博<!-- raw HTML omitted -->: 侠士还记得2013年开启的“我为剑网3代言活动”吗？<!-- raw HTML omitted -->随着《剑网3》全平台上线的临近，全新激励回馈活动震撼来袭，这次就是要简单直接！继登录送校服、满级送校服后，免费校服再来三套！5471套校服任你选！拉上亲友，一起来拿好礼吧~6月6日活动正式开启！<!-- raw HTML omitted --><!-- raw HTML omitted -->很多侠士想让官博送手机！这次真的来送啦~转关抽1位幸运侠士送上【Xiaomi 14 Pro 16+512版】，再抽1位幸运侠士送上【iPad Air6 512版】！再再从评论区抽10位幸运侠士送上【10000通宝】<!-- raw HTML omitted -->@微博抽奖平台<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->✦ 【送校服啦！不止一套】满级即可拿自选券！参与好友同行活动最高还能额外拿3张校服自选券！手握1+3张校服自选券，踏上大唐搭配界王者之路！&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgQuZCOMT">是谁，在剑网三上班 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogquzcomt/">
    
    
    
    
    
      
    
    是谁，在剑网三上班 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgS3L1CC6">偷感很重，悄悄幸福[老师爱你] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogs3l1cc6/">
    
    
    
    
    
      
    
    偷感很重，悄悄幸福<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgSBmys1g">转发微博 - 转发 @暁Mizuki:&amp;ensp;＜映画「帰ってきた あぶない刑事」（5月24日公開）早瀬梨花役・西野七瀬モデルプレスインタビュー＞ #なぁちゃん# 网页链接 [...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogsbmys1g/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@暁Mizuki<!-- raw HTML omitted -->: ＜映画「帰ってきた あぶない刑事」（5月24日公開）早瀬梨花役・西野七瀬モデルプレスインタビュー＞ <!-- raw HTML omitted --><!-- raw HTML omitted -->#なぁちゃん#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default.png&quot;</a> referrerpolicy=&ldquo;no-refer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTGWqW8X">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram##乃木坂46ANN##通知各位听众##我真的加tag了哦#详情请听听这周的广播哦 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogtgwqw8x/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTH498Ss">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里乃木恋新卡 [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogth498ss/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->乃木恋新卡 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hq90wnn7u7j30hs0nqn37.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hq90wnn7u7j30hs0nqn37.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OgTntaSaU">好神奇，能听懂日语的时候感觉好神奇</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ogtntasau/">
    
    
    
    
    
      
    
    好神奇，能听懂日语的时候感觉好神奇  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgNn0c0Vh">m [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ognn0c0vh/">
    
    
    
    
    
      
    
    m <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgPfn64dM">久保始球式那天的預售票賣光啦！[努力] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogpfn64dm/">
    
    
    
    
    
      
    
    久保始球式那天的預售票賣光啦！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OgQiqp4Jc">你保寫blog 了！可喜可賀👏👏👏 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ogqiqp4jc/">
    
    
    
    
    
      
    
    你保寫blog 了！可喜可賀👏👏👏 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgOI2j2Uo">因为我是免费会员，看不到老赵连载的最新内容，不过听说这篇连载里面有提到很多之前老赵没有提到的内容（包括最后一集动刀的事情）所以各位再等等吧（）#围棋#围...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogoi2j2uo/">
    
    
    
    
    
      
    
    因为我是免费会员，看不到老赵连载的最新内容，不过听说这篇连载里面有提到很多之前老赵没有提到的内容（包括最后一集动刀的事情）<!-- raw HTML omitted --><!-- raw HTML omitted -->所以各位再等等吧（）<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defaul">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_defaul</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgQjd2Pvx">是时候要请虎丸吃和府捞面了#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogqjd2pvx/">
    
    
    
    
    
      
    
    是时候要请虎丸吃和府捞面了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgQw25cRl">得，不用请了 - 转发 @找借口安静:&amp;ensp;是时候要请虎丸吃和府捞面了#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogqw25crl/">
    
    
    
    
    
      
    
    得，不用请了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@找借口安静<!-- raw HTML omitted -->: 是时候要请虎丸吃和府捞面了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgRvSosEl">有朋友问我，日本棋院颁发的证书，段位是不是职业棋手和业余棋手同款。答案：不是。区别：业余棋手和职业棋手，最大的区别就是，职业棋手在名字前面有“棋士”，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogrvsosel/">
    
    
    
    
    
      
    
    有朋友问我，日本棋院颁发的证书，段位是不是职业棋手和业余棋手同款。<!-- raw HTML omitted --><!-- raw HTML omitted -->答案：不是。<!-- raw HTML omitted --><!-- raw HTML omitted -->区别：业余棋手和职业棋手，最大的区别就是，职业棋手在名字前面有“棋士”，业余没有。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_car">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_car</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgS5BnSH8">我觉得很多人看不起日本棋院，已经到了随便拿一张日本棋院颁发的业余证书就当是职业了以下是日本棋院官网，请查收网页链接#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogs5bnsh8/">
    
    
    
    
    
      
    
    我觉得很多人看不起日本棋院，已经到了随便拿一张日本棋院颁发的业余证书就当是职业了<!-- raw HTML omitted --><!-- raw HTML omitted -->以下是日本棋院官网，请查收<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam">https://m.weibo.cn/p/index?extparam</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OgSVShZtj">发布了头条文章：《一力辽本因坊战达成连霸，余正麒无力回天》 #围棋# 围棋 一力辽本因坊战达成连霸，余正麒无力回天 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ogsvshztj/">
    
    
    
    
    
      
    
    发布了头条文章：《一力辽本因坊战达成连霸，余正麒无力回天》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgNBp43zs">久保史绪里via.岡田准一 X信长时代的女儿久保史绪里桑的脸颊软乎乎的，很难下得了手去猛抓。因为当时是突然这样做的所以还以为会被她讨厌，但再会的那天她还是一...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ognbp43zs/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.岡田准一 X<!-- raw HTML omitted -->信长时代的女儿<!-- raw HTML omitted -->久保史绪里桑的脸颊软乎乎的，很难下得了手去猛抓。<!-- raw HTML omitted -->因为当时是突然这样做的所以还以为会被她讨厌，但再会的那天她还是一大早就叫我「父亲！」。<!-- raw HTML omitted -->没被她讨厌真的太 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgO4mClAf">久保史绪里麦当劳「スパイシーチキンマックナゲット（麦辣鸡块）」新CM🍔🍟 短版 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogo4mclaf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->麦当劳「スパイシーチキンマックナゲット（麦辣鸡块）」新CM🍔🍟 短版 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgR29jVMX">更新了tag - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# .#乃木坂46ANN##详情请听听广播##大家的要求很严格##衣袖又折起来了##大家都温柔一点吧# .#乃木坂46...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogr29jvmx/">
    
    
    
    
    
      
    
    更新了tag<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extpara</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgR2ngysH">久保史绪里#shiorigram##乃木坂46ANN##通知各位听众##我真的加tag了哦#详情请听听这周的广播哦 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogr2ngysh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OgRYjzkMf">久保史绪里乃木恋新卡 [图片][图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ogryjzkmf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->乃木恋新卡 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hq90won1ouj30h">https://tvax3.sinaimg.cn/large/006z6nxLgy1hq90won1ouj30h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1cZ421s7e8">陈翔六点半：哪个男友经不起这样的考验</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1cz421s7e8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Ry411875K">从“和而不同”到“独立自主”：亚洲智慧的独特魅力【这就是中国】</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ry411875k/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/364392686/answer/3511392176">乌鸦校尉赞同了回答: 《庆余年》小说最后的结局是什么？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-364392686-answer-3511392176/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/370967275/answer/3516212266">张敬信回答了问题: 利用python如何将多个Excel文件合并到一个excel中，sheet命名为excel的名字？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-370967275-answer-3516212266/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/522856095/answer/3515848796">乌鸦校尉赞同了回答: 你最意外的一笔收入是什么？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-522856095-answer-3515848796/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657591428/answer/3515246177">乌鸦校尉赞同了回答: 如何看待网传斯坦福大学毕业生上岸皖北乡镇公务员？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657591428-answer-3515246177/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657649755/answer/3515369239">乌鸦校尉赞同了回答: 就平均个体而言，农耕民族的平均战斗力和游牧民族的平均战斗力哪个强？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657649755-answer-3515369239/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657656571/answer/3515707776">乌鸦校尉赞同了回答: 外交部称「如果欧方一意孤行，中方绝不会坐视不管，将采取一切必要措施」，哪些信息值得关注？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657656571-answer-3515707776/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657735875/answer/3515840523">乌鸦校尉赞同了回答: 34 项重罪指控成立，特朗普成美国史上首位被判有罪的前总统，这意味着什么？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657735875-answer-3515840523/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700894235">量子位发表了文章: 星环科技重磅发布知识平台TKH，助力企业打造可信赖的AI Infra</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700894235/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700894964">量子位发表了文章: OpenAI被曝帮苹果Siri换脑，微软急了：CEO约谈奥特曼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700894964/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700896387">量子位发表了文章: 这家产品AI用户过亿，月活第一，覆盖学习办公教育，有人用来赚钱</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700896387/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700901391">量子位发表了文章: AI在咳嗽中检出癌症，不信？世卫组织正全球推广</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700901391/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700903325">量子位发表了文章: 1/3年轻人愿和AI交朋友，超1成年轻人已经靠AIGC赚过钱了｜Soul App报告分享</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700903325/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/700914231">量子位发表了文章: 清华“天眸芯”登Nature封面！全球首款类脑互补视觉芯片，施路平团队最新成果</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-700914231/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701021169">量子位发表了文章: 无需3D数据也能训练，港科&amp;港中文联手华为推出3D自动驾驶场景生成模型</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-31</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701021169/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

